Evaluation of alternative oseltamivir (Tamiflu) dosing strategies for use during influenza prophylaxis

Trial Profile

Evaluation of alternative oseltamivir (Tamiflu) dosing strategies for use during influenza prophylaxis

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs Oseltamivir (Primary) ; Probenecid
  • Indications Influenza virus infections
  • Focus Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 10 Sep 2009 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
    • 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Apr 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top